Famke Schneiders

DR.

20112019
If you made any changes in Pure these will be visible here soon.

Research Output 2011 2019

  • 21 Article
  • 2 Chapter
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam
2019

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Palma, D. A., Olson, R., Harrow, S., Correa, R. J. M., Schneiders, F., Haasbeek, C. J. A., Rodrigues, G. B., Lock, M., Yaremko, B. P., Bauman, G. S., Ahmad, B., Schellenberg, D., Liu, M., Gaede, S., Laba, J., Mulroy, L., Senthi, S., Louie, A. V., Swaminath, A., Chalmers, A. & 5 othersWarner, A., Slotman, B. J., de Gruijl, T. D., Allan, A. & Senan, S., 2019, In : BMC Cancer. 19, 1, 816.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2017

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

de Bruin, R. C. G., Veluchamy, J. P., Lougheed, S. M., Schneiders, F. L., Lopez-Lastra, S., Lameris, R., Stam, A. G., Sebestyen, Z., Kuball, J., Molthoff, C. F. M., Hooijberg, E., Roovers, R. C., Santo, J. P. D., van Bergen en Henegouwen, P. M. P., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 17 Oct 2017, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticleAcademicpeer-review

2015

Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells

Schneiders, F. L., Huijts, C. M., Mantici, A., Menks, M. A. C., Scotet, E., Veerhuis, R., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2015, In : Clinical Immunology. 158, 1, p. 92-99

Research output: Contribution to journalArticleAcademicpeer-review

32 Downloads (Pure)

Invariant Natural Killer T cells and Vy9V82-T cells: between in-betweeners

Schneiders, F. L., 2015

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

File
2014

Bispecific antibody platforms for cancer immunotherapy

Lameris, R., de Bruin, R. C. G., Schneiders, F. L., Henegouwen, P. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Critical Reviews in Oncology / Hematology. 92, 3, p. 153-165

Research output: Contribution to journalArticleAcademicpeer-review

CD1d-Restricted Antigen Presentation by V gamma 9V delta 2-T Cells Requires Trogocytosis

Schneiders, F. L., Prodohl, J., Ruben, J. M., O'Toole, T. G., Scheper, R. J., Bonneville, M., Scotet, E., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Cancer Immunology Research. 2, 8, p. 732-740

Research output: Contribution to journalArticleAcademicpeer-review

Exploiting theCD1d-iNKT cell axis for potentiation of DC-based cancer vaccines

Lameris, R., Schneiders, F. L., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Methods in Molecular Biology. 1139, p. 155-165

Research output: Contribution to journalArticleAcademicpeer-review

Vgamma9Vgamma2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

Werter, I. M., Schneiders, F. L., Scotet, E., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : OncoImmunology. 3, 9, e955343.

Research output: Contribution to journalArticleAcademicpeer-review

2012

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α

Schneiders, F. L., de Bruin, R. C. G., Santegoets, S. J. A. M., Bonneville, M., Scotet, E., Scheper, R. J., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Clinical Immunology. 142, 2, p. 194-200

Research output: Contribution to journalArticleAcademicpeer-review

An alpha-galactosylceramide nose job shapes up iNKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Immunotherapy. 4, 1, p. 20-21

Research output: Contribution to journalArticleAcademicpeer-review

An α-galactosylceramide nose job shapes up iNKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., Jan 2012, In : Immunotherapy. 4, 1, p. 20-1 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

Bulldozing Beta-linked glycolipids for recognition by invariant NKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Immunotherapy. 4, 1, p. 20-20

Research output: Contribution to journalArticleAcademicpeer-review

Bulldozing β-linked glycolipids for recognition by invariant NKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., Jan 2012, In : Immunotherapy. 4, 1, p. 20

Research output: Contribution to journalArticleAcademicpeer-review

Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer

Schneiders, F. L., Scheper, R. J., Bontkes, H. J., von Blomberg, B. M. E., Eertwegh, A. J. M., de Gruijl, T. D. & Van Der Vliet, H. J., 1 Jan 2012, Natural Killer T cells: Balancing the Regulation of Tumor Immunity. Springer New York, p. 169-183 15 p.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Gram-positive bacteria: a major microbial 'turn-on' for invariant NKT cells

de Bruin, R. C. G., Schneiders, F. L., Santegoets, S. J. A. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2012, In : Immunotherapy. 4, 1, p. 19-19

Research output: Contribution to journalArticleAcademicpeer-review

2011

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Schneiders, F. L., Scheper, R. J., von Blomberg, B. M. E., Woltman, A. M., Janssen, H. L. A., van den Eertwegh, A. J. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, J. J., 2011, In : Clinical Immunology. 140, 2, p. 130-141

Research output: Contribution to journalArticleAcademicpeer-review

Clinical trials with a-Galactosylceramide (KRN7000) in advanced cancer

Schneiders, F. L., Scheper, R. J., Bontkes, H. J., von Blomberg, B. M. E., van den Eertwegh, A. J. M., de Gruijl, T. D. & van der Vliet, J. J., 2011, Natural killer T cells: Balancing the regulation of tumor immunity, Cancer drug discovery and development. Springer Science + Business Media, p. 1

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Nuancing the proposed role of NKT cells in aging

Schneiders, F. L., de Bruin, R., Exley, M. A. & van der Vliet, J. J., 2011, In : Virulence. 2, 2, p. 170-170

Research output: Contribution to journalArticleAcademicpeer-review

Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin

Schneiders, F. L., van den Berg, H. P., Peters, G. J., Verheul, H. M. W. & van der Vliet, J. J., 2011, In : Medical Oncology. 28, 4, p. 1136-1139

Research output: Contribution to journalArticleAcademicpeer-review